REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.50
Bid: 17.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 3.00 (17.647%)
Open: 18.50
High: 18.50
Low: 18.50
Prev. Close: 18.50
STCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

11 Jan 2023 07:00

RNS Number : 3291M
Steppe Cement Limited
11 January 2023
 

11 January 2023

Steppe Cement Ltd

Preliminary Update for the Year ended 31 December 2022

Steppe Cement Limited ("Steppe Cement") recorded good revenue growth in 2022 with positive market conditions for the business. The focus has been on the domestic market where Steppe Cement's market share remains resilient.

Steppe Cement recorded revenue for the year ended 31 December 2022 of 40,023 million Tenge ("KZT"), which was 11% higher than the KZT 36,020 million recorded for the previous year. In 2022, cement sales volume was 1,670,174 tonnes, being slightly lower than the 1,688,544 tonnes achieved for the previous year. The average price (ex-VAT) for delivered cement was KZT 23,963 per tonne in 2022, representing a 12% increase on the KZT 21,332 per tonne achieved in 2021. The average ex-factory price in 2022 stood at KZT 20,970 per tonne compared to 18,134 in 2021, which represents USD 45 per tonne based on 2022's average exchange rate of USD/KZT 461 vs 426 in 2021. As we were limited by our production, we concentrated on the markets closer to our factory.

In 2022, the cement market consumption in Kazakhstan remained at 11.6 million tonnes.

Steppe Cement's local market share was 14.5% compared to 13.9% in 2021. Exports have been reduced to zero to optimize logistics and concentrate sales in more attractive domestic markets. Overall, Kazakhstan imported 0.7 million tonnes of cement (vs 0.8 million tonnes in 2021) and exported 1.1 million tonnes (vs 1.6 million tonnes in 2021).

Official inflation in Kazakhstan was 20.3% and will have a significant impact on production costs in 2023, but we continue our capex program to increase production capacity of clinker and higher grades of cement by the summer of 2023, as well as to reduce power and coal consumption.

There were extreme weather conditions in Kazakhstan and logistical difficulties in the railway network in November and December 2022. The board is working to try to minimise their impact in 2023.

The full results and audited accounts denominated in USD are expected to be published in May 2023.

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser contact: Stephen Allen or Andrew Thomson on +61 8 9480 2500.

Broker contact: Charlie Cryer at +44 20 3440 680

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFIFIFLAILLIV
Date   Source Headline
6th Oct 20107:00 amRNSMarket Update for 3Q 2010
30th Sep 20108:06 amRNSUnderwritten Offer of Shares
3rd Sep 20107:00 amRNSInterim Results
27th Jul 20107:00 amRNSMarket Update for 1H 2010
10th May 20108:22 amRNSAGM Results
27th Apr 20107:00 amRNSMarket Update for 1Q 2010
27th Apr 20107:00 amRNSAnnual Report
12th Apr 20107:00 amRNSPreliminary Results Update
3rd Feb 20107:00 amRNSPreliminary Results
30th Oct 20097:00 amRNSQuarterly Results
2nd Sep 20097:00 amRNSInterim Results
19th Aug 20097:00 amRNSHolding(s) in Company
3rd Aug 20097:00 amRNSPreliminary Interim Results
25th Jun 20097:00 amRNSHolding(s) in Company
14th May 20098:46 amRNSHolding(s) in Company
11th May 200910:03 amRNSQuarterly Results
7th May 20097:00 amRNSUnderwritten Share Offer Results
24th Apr 20097:00 amRNSAnnual Report
14th Apr 200910:00 amRNSUnderwritten Offer of Shares
14th Apr 20097:31 amRNSPreliminary Results Update
16th Feb 20097:50 amRNSPreliminary Results
8th Jan 20097:02 amRNSDirector Shareholding
6th Jan 20097:00 amRNSHolding(s) in Company
19th Dec 20087:00 amRNSDirector Appointment
29th Oct 20088:00 amRNSSuccessful Commissioning of Line 6
17th Oct 20088:02 amRNSDirector Shareholding
17th Oct 20087:00 amRNSRefinancing of Credit Line
5th Sep 20089:01 amRNSInterim Results - Replacement
5th Sep 20088:16 amRNSInterim Results
19th May 20087:00 amRNSResult of AGM
16th May 20087:00 amRNSResignation of Director
6th May 20087:01 amRNSHolding(s) in Company
21st Apr 20081:55 pmRNSAnnual Report and Accounts
16th Apr 20087:00 amRNSFinal Results
21st Dec 20077:00 amRNSDirector/PDMR Shareholding
22nd Nov 20077:01 amRNSDirector/PDMR Shareholding
7th Sep 20077:00 amRNSCorrection to Interim Results
5th Sep 200711:46 amRNSInterim Results
24th Aug 20077:00 amRNSHolding(s) in Company
20th Aug 20078:22 amRNSAIM Rule 26 Information
20th Aug 20078:13 amRNSHolding(s) in Company
7th Aug 20077:00 amRNSNew Significant Shareholder
16th Jul 20079:11 amRNSHolding(s) in Company
5th Jul 20078:01 amRNSDirector/PDMR Shareholding
2nd Jul 200710:05 amRNSExtension to Credit Lines
25th Jun 20077:45 amRNSUpdate on Trading Position
25th May 20078:09 amRNSResult of AGM
21st May 20078:53 amRNSAnnual Report and Accounts
10th May 20078:39 amRNSHolding(s) in Company
8th May 20078:24 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.